Mar 31, 2019

United Therapeutics Q1 2019 Earnings Report

Total Revenue
$363M
Previous year: $389M
-6.8%
EPS
$3.58
Previous year: $3.76
-4.8%
Gross Profit
$334M
Previous year: $336M
-0.7%
Cash and Equivalents
$791M
Previous year: $933M
-15.2%
Free Cash Flow
-$653M
Previous year: $238M
-374.0%
Total Assets
$3.73B
Previous year: $3.02B
+23.4%

United Therapeutics

United Therapeutics

United Therapeutics Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income